The relationship between susceptibility to transformation in vitro by different oncogenes and terminal differentiation was analyzed in embryonic quail myogenic cells. Infection with Rous sarcoma virus (RSV), Fujinami sarcoma virus (FSV), avian erythroblastosis virus (AEV), and the avian myelocytomatosis virus MC29 led to rapid and massive transformation. Transformed cells had distinctive morphological alterations, increased proliferation rates, and the ability to grow in agar suspension. Furthermore, homogeneously transformed cultures failed to fuse into multinucleated myotubes and to express muscle-specific genes. However, cloned populations of RSV-, FSV-, and AEV-transformed myogenic cells could, under appropriate culture conditions, partially differentiate into atypical "revertant" myotubes. In contrast, competence for terminal differentiation was completely and irreversibly suppressed on transformation by MC29. The specificity of action of a given oncogenic sequence on the inhibition of differentiation was further studied by using conditional and nonconditional transformation mutants. Myogenic cells infected with temperature-sensitive (ts) mutants of RSV and FSV exhibited a fully reversible block of differentiation after shift to restrictive temperature, while cells infected with ts34 AEV were not temperature sensitive for differentiation. Cultures infected with the partially transformation-defective mutant of MC29 tdlOH were morphologically transformed and acquired anchorage independence for proliferation but maintained a residual competence for terminal differentiation.
Retrovirus-induced transformation in vitro is often accompanied by derangement in the expression of cell type-specific differentiated functions (1) (2) (3) (4) . The available evidence suggests that the block of differentiation is under continuous control of the transforming gene products: when temperature-sensitive (ts) transformation mutants of Rous sarcoma virus (RSV) or avian erythroblastosis virus (AEV) were used, a simple shift to the nonpermissive temperature suppressed the transformed state and allowed the expression or reexpression of differentiated functions in infected cells belonging to different lineages (5) (6) (7) (8) (9) . Viral infection, however, does not inevitably result in cell transformation and block of differentiation. In a few cases, transforming retroviruses are without detectable effects on host cells: (i) macrophages infected with RSV (10) or AEV (11) remain untransformed and functionally differentiated, albeit producing transforming viral progeny and synthesizing the transforming proteins, and (ii) ts AEV-transformed erythroblasts superinfected by the myelocytomatosis virus MC29 (11) can nonetheless differentiate after a shift to the restrictive temperature.
In RSV-transformed myogenic cells (5, 6) , differentiation is prevented by the continuous action of pp60src, the RSV transforming gene product (12) . The block of differentiation, however, is reversible and a variable proportion (-50%0) of the transformed cells can, under appropriate culture conditions, fuse into atypical multinucleated myotubes that express muscle-specific markers such as acetylcholine receptors, myosin, desmin and MM-creatine kinase (referred to as "revertant" myotubes, refs. 13 and 14) .
We have further investigated the competence for myogenic differentiation in RSV-transformed cells and in cells infected with three independently isolated strains of transforming retroviruses-Fujinami sarcoma virus (FSV), AEV, and MC29-that differ in target cell specificity, oncogenic sequences, intracellular localization of the transforming proteins, and putative mechanism of transformation (1). Accordingly, experiments were made to test whether (i) myogenic cells can be transformed by oncogenes other than src, (ii) the differentiation program can be affected by the various transforming proteins, (iii) there are distinctive features in the block of differentiation imposed by different oncogenes, and (iv) the integrity of the viral sequences required for leukemogenesis in vivo is also required for block of myogenic differentiation in vitro.
MATERIALS AND METHODS
Quail embryo myoblasts were prepared from the breast muscles of 10-day-old Japanese quail embryos as described (14) . Growth medium for all transformed cells consisted of Dulbecco's modified Eagle's medium supplemented with 10% tryptose phosphate broth/10% fetal calf serum/1% chicken serum. To assay myogenic differentiation, cells were plated on collagen-coated 35-mm dishes at 105 cells per dish in growth medium. Twenty-four hours later, cultures were fed with differentiation medium, which consisted of F14 (15) medium supplemented with 2% fetal calf serum and insulin (Sigma) at 5 ,ug/ml, and then incubated at the appropriate temperature. The permissive temperature for ts transformation mutants was 35°C; the restrictive temperature was 41°C.
Stocks of MC29 (RAV-1), MC29 (tdB77), tdlOH (RAV-1) ( Fig. 2 legend).
The viral pp6Osrc and pP1409ag-fPS products were assayed using the immunocomplex assay of Collett and Erikson (16) as modified (17, 18) . The tumor-bearing rabbit sera, which precipitate RSV pp60src, were the gift of P. Enrietto. Immunofluorescence experiments were performed as described (14 tClonal strains were cultured in differentiation medium and scored at day 3. +, 3-30% nuclei in revertant myotubes; + + +, >90% fusion; -, no fusion.
tClonal strains were cultivated in differentiation medium and scored at day 5 by immunofluorescence. +, Sarcomeres in the majority of myotubes; (+), abortive sarcomere in revertant myotubes; -, no sarcomeres.
undergoing differentiation. However, as reported for RSV (13, 14) , homogeneously transformed cultures of FSV-and AEV-infected cells showed a residual competence for differentiation, as evidenced by the persistent presence of atypical, revertant myotubes. MC29-transformed cells, on the contrary, appeared to be irreversibly incapable of differentiating (see below).
Infection of myogenic cells with ts transformation mutants of RSV, FSV, and AEV at permissive temperature (350C) produced the same pattern of alterations described for parental viruses. On shift to restrictive temperature (41°C), >90% of ts RSV-and ts FSV-transformed cells differentiated into elongated, myosin-positive, multinucleated myotubes that further maturated, organizing sarcomeres and showing spontaneous contractile activity ( Fig. 1 E and F) , as described for uninfected cells. ts34 AEV-transformed cells, on the contrary, did not resume a fully normal phenotype after shift to 41°C and, resembling wild-type (wt) AEVtransformed cells, could differentiate only into revertant myotubes (Fig. 1G) . Moreover, increased deoxyglucose uptake was not temperature sensitive (data not shown), suggesting that the lesion in ts34 AEV might be less penetrant in myogenic cells than in fibroblasts or erythroblasts (19) . (Fig. 2 A and B) . p68erbn, the other putative transforming product of the erb oncogene, was not assayed in this study, but it is known to be produced by the AEV strain used (20 differentiation medium, while expressing a number ofmusclespecific markers (data not shown), were atypical in shape, with centrally clustered nuclei, and failed to assemble normal striated myofibrils (Fig. lA-C) . In revertant myotubes arising from AEV-transformed cells, myosin appeared to be assembled into abortive sarcomere-like structures (Fig. 1C) . Clonal strains of MC29-transformed cells were also developed but, although selected by the same criteria, were uniformly negative for expression of all differentiation markers tested. The MC29 clonal strains synthesized the product of the myc oncogene, P1105ag-mYc (Fig. 2C) , which showed the characteristic nuclear localization (Fig. 1D) (Table 1) and clonal strains derived therefrom synthesized the expected transforming product (Fig. 2C) . Unlike MC29, however, tdlOH-transformed cells could differentiate into revertant myotubes (Fig. 1H) . A peculiar feature of tdlOH noted in the soft agar cloning experiments is worth mentioning. When freshly infected cells were plated in soft agar, there was a 5-to 7-day lag before they began to grow, whereas no such lag was observed for parental MC29-infected cells. On the contrary, there was no detectable lag when tdlOH homogeneously transformed cells were assayed for efficiency of plating in soft agar, and colonies developed in times comparable with those of MC29, albeit with some reduction in number and size (Table 1) .
DISCUSSION
In the present experiments, we have analyzed and compared the effects of functionally different oncogenes-src,fps, erb, proteins structurally homologous to members of the src family, yet without detectable enzymatic activity in vitro (erbB) (20, 25) . The data show that the expression of each of these oncogenes resulted in rapid and massive transformation of infected cells. Transformed cells were anchorage independent for proliferation and synthesized the specific putative transforming proteins. AEV contains two distinct oncogenes that are separately expressed, erbA as a p755a5-erbA fusion protein and erbB as a p68erbB protein (20, 28) . The main transforming capacity for both fibroblasts and erythroblasts seems to reside in erbB, while erbA appears to potentiate erbB action (28, 29) .
Although the lesion(s) in ts mutants of AEV has not yet been mapped, their temperature sensitivity for transformation in fibroblasts and block of differentiation in erythroblasts indicate a probable mutation in the ,rbB domain (28) . The partial temperature sensitivity of ts4AEV in myogenic cells could reflect either a residual transforming activity of the erbB product or a specific role playe4 by the erbA product in control of differentiation of AEV-fransformed myogenic cells. Clarification of this point will require use of the recently developed nonconditional mutants in erbA and erbB (29) .
The data reported here show that myc is the most potent oncogene, affecting both control of proliferation and competence for differentiation irreversibly. The presence of revertant myotubes in myogenic clones transformed by tdlOH suggests that the myc sequence, which controls leukemogenesis and pathogenicity, is required in its entirety for the irreversible block of myogegic differentiation. The expression of c-myc, the cellular hjmologue of v-myc, has recently been shown to be coordind ely regulated with cell cycle progression in normal cells (30) . In addition, recent studies have shown that introduction of v-myc into quail and rat embryo fibroblasts results in an enhanced rate of proliferation (31, 32) . Our data indicate that expression of v-myc conferred to myogenic cells two altered growth properties: a greatly expanded lifespan (immortalization?) and a very high proliferation rate at clonal density either on plastic or in suspension. Hence, the v-myc-induced block of differentiation may be envisaged as an indirect consequence of relaxed growth control, because expression of the myogenic differentiation program requires previoIs withdrawal from the cell cycle (33) . Intriguingly, in chicken chondroblasts (unpublished work) and macrophages (10) , where, at variance with myogenic cells, expression of the differentiation program is compatible with cell proliferation, MC29 transformation leads to growth alterations yet leaves synthesis of the specific differentiated products unaffected.
The present results and the above considerations are consistent with the existence of two groups of oncogenes primarily acting either on the expression of differentiation (src and fps) or on the control of proliferation (myc). The first group is further characterized by a distinctive instability in maintenance of the transformed phenotype in myogenic cells that can be modulated by environmental cues.
